middle.news

MedAdvisor Reshapes US Sales Amid 3Q Revenue Slump, Eyes 15% Growth in FY26

4:53am on Monday 2nd of June, 2025 AEST Healthcare
Read Story

MedAdvisor Reshapes US Sales Amid 3Q Revenue Slump, Eyes 15% Growth in FY26

4:53am on Monday 2nd of June, 2025 AEST
Key Points
  • 3Q FY25 revenue down 49%, gross profit down 52%, impacted by US market challenges
  • US commercial team restructured with new leadership and sales strategy
  • Successful $5 million capital raise supports ongoing strategic initiatives
  • Cost savings program targeting A$12.8 million by FY26 to improve margins
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about MDR
OPEN ARTICLE